Tyvaso 0.6 MG starter kit
Ended Awarded Last action
- Contract number
- 36C24526N0386
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,614
Award facts
- Contract value 100% obligated
- $17,613.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lake Mary, FL 32746, USA
Award details come from SAM.gov/FPDS.
About this award
United Therapeutics Corp has been awarded a delivery order valued at $17,613.64 by the Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5) for Tyvaso 0.6 mg starter kits. The award, issued on March 6, 2026, is a firm fixed-price delivery order with an ultimate completion date of March 10, 2026, and will be performed in Lake Mary, Florida. This contract operates under the GSA's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB) and includes no set-aside designation. United Therapeutics Corp, a biotechnology manufacturer specializing in treatments for pulmonary arterial hypertension and select oncology conditions, is registered as a self-certified small disadvantaged business.
This delivery order is executed under a larger $207.1 million single-award Blanket Purchase Agreement between United Therapeutics Corp and the Department of Veterans Affairs National Acquisition Center, effective through April 23, 2026. The BPA encompasses four critical pharmaceutical products—Unituxin, Remodulin, Tyvaso, and Orenitram—and enables Veterans Integrated Service Networks across the country to procure these specialized medications at pre-negotiated firm fixed-prices without competition. This structure allows the Veterans Health Administration to efficiently manage supply chains and ensure reliable access to these essential therapeutic products across its integrated healthcare network nationwide.
Quick answers
Who was awarded contract 36C24526N0386?
36C24526N0386 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 6, 2026.
How much is contract 36C24526N0386 worth?
The government has obligated $17,614 on 36C24526N0386.
Is contract 36C24526N0386 an order under another contract?
Yes. 36C24526N0386 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0386 competed?
The extent of competition for 36C24526N0386 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award